DeepMed Research

Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer

Phase 2

Conditions: Unresectable Metastatic Right-sided Colon Cancer Starting First-line Combination Chemotherapy
Unresectable Metastatic Right-sided Colon Cancer, Stage IV

Interventions: Drug: A-FOLFOXIRI
Drug: Arm II (A-FOLFOX/A-FOLFIRI)

First Posted Date: 2018-08-22

Last Posted Date: 2020-10-19

Lead Sponsor: Yonsei University

Target Recruit Count: 120

Registration Number: NCT03641976

Locations: 🇰🇷
Yonsei Cancer Center, Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Clinical Effects of Diquas-S for Patients With Dry Eye After Cataract Surgery

Not Applicable

Completed

Conditions: Dry Eye
Cataract Surgery

Interventions: Drug: 1. Use of preservative free diquafosol ophthalmic solution after cataract surgery
Drug: 2. Use of preservative containing diquafosol ophthalmic solution after cataract surgery
Drug: 3. Use of preservative free sodium hyaluronate ophthalmic solution after cataract surgery

First Posted Date: 2018-08-21

Last Posted Date: 2020-09-30

Lead Sponsor: Yonsei University

Target Recruit Count: 150

Registration Number: NCT03640351

Locations: 🇰🇷
Department of Ophthalmology, Yonsei Univeristy College of Medicine, Seoul, Korea, Republic of

n-3 Fatty Acids in Enteral Formula on NK Cell Activity

Not Applicable

Completed

Conditions: Enteral Nutrition

Interventions: Dietary Supplement: vegetable (canola, flaxseed) derived n-3 fatty acid
Dietary Supplement: soybean oil

First Posted Date: 2018-08-20

Last Posted Date: 2018-08-20

Lead Sponsor: Yonsei University

Target Recruit Count: 94

Registration Number: NCT03638661

Predictability of Preoperative Carotid Artery Corrected Flow Time for Hypotension After Spinal Anesthesia in Patients Undergoing Cesarean Section

Completed

Conditions: Cesarean Section

Interventions: Diagnostic Test: Doppler sonographic measurement

First Posted Date: 2018-08-15

Last Posted Date: 2020-01-07

Lead Sponsor: Yonsei University

Target Recruit Count: 38

Registration Number: NCT03631329

Locations: 🇰🇷
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine, Seoul, Korea, Republic of

Optical CoherenCe Tomography-gUided Coronary Intervention in Patients With Complex lesIons: a Randomized Controlled Trial (OCCUPI Trial)

Not Applicable

Completed

Conditions: Coronary Artery Disease

Interventions: Device: Angiography-guided PCI
Device: OCT-guided PCI

First Posted Date: 2018-08-10

Last Posted Date: 2023-11-14

Lead Sponsor: Yonsei University

Target Recruit Count: 1604

Registration Number: NCT03625908

Locations: 🇰🇷
Yonsei Cardiovascular Center and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer

Phase 2

Conditions: Recurrent Ovarian Cancer

Interventions: Radiation: Involved-field radiotherapy

First Posted Date: 2018-08-07

Last Posted Date: 2018-08-07

Lead Sponsor: Yonsei University

Target Recruit Count: 107

Registration Number: NCT03618706

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Korea, Republic of

Postoperative Muscular Pain, ETOIMS (Electrical Twitch Obstructive Intramuscular Stimulation)

Phase 3

Conditions: Disease Status of Pancreatobiliary Tract , ( Especially Who Need to Undergo Pancreaticoduodenectomy)

Interventions: Procedure: ETOIMS(Electrical Twitch Obtaining Intramuscular Stimulation)

First Posted Date: 2018-08-07

Last Posted Date: 2018-08-07

Lead Sponsor: Yonsei University

Target Recruit Count: 44

Registration Number: NCT03619343

Locations: 🇰🇷
GangnamSeverance Hospital, Seoul, Korea, Republic of

Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer

Conditions: Metastatic Breast Cancer With HER2 Positive
Triple Negative Breast Cancer

Interventions: Procedure: Brain MRI

First Posted Date: 2018-08-06

Last Posted Date: 2020-10-27

Lead Sponsor: Yonsei University

Target Recruit Count: 200

Registration Number: NCT03617341

Locations: 🇰🇷
Yonsei Cancer Center, Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Durvalumab (MEDI4736) and Tremelimumab in Hormone Receptor-positive, Hypermutated Metastatic Breast Cancer Identified by Whole Exome Sequencing

Phase 2

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: Durvalumab with Tremelimumab

First Posted Date: 2018-08-01

Last Posted Date: 2022-01-03

Lead Sponsor: Yonsei University

Target Recruit Count: 30

Registration Number: NCT03608865

Locations: 🇰🇷
Yonsei Cancer Center, Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

The Evaluation of Erector Spinae Plane Block for the Pain Control of Thoracic Postherpetic Neuralgia

Not Applicable

Withdrawn

Conditions: Thoracic Postherpetic Neuralgia

Interventions: Procedure: thoracic paravertebral block(10 mL 0.25% ropivacaine with dexamethasone 5mg)
Procedure: erector spinae plane block (20 mL of 0.25% ropivacaine with dexamethasone 5mg)

First Posted Date: 2018-07-23

Last Posted Date: 2019-02-12

Lead Sponsor: Yonsei University

Registration Number: NCT03595046

Locations: 🇰🇷
Dept. of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy